Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FORGOTTEN HISTORY: 25 | History Defined

Salmonella Outbreak 2026: Check Your Pantry for These Two Common Health Supplements

Supplements are intended to boost health, but a recent multi-state Salmonella outbreak in 2026 has turned morning wellness routines into a significant risk. Two major “superfood” brands are currently at the center of a federal investigation. The FDA and CDC are tracking at least 65 illnesses across 28 states, with…

Budget and the Bees

Mouthwash Alert: 80,000 Bottles Recalled Due to Serious Labeling Error

Your morning hygiene routine is supposed to be the simplest part of your day. You reach for the bottle, rinse, and go. But a massive new recall of over 80,000 bottles of Parodontax Active Gum Health mouthwash has turned a basic habit into a potential risk. The FDA has issued…

Budget and the Bees

Fatal Botulism Risk: Recalled Tuna Inadvertently Shipped to Stores in 9 States

A simple sandwich shouldn’t be a gamble with your life, but for residents in nine states, the pantry staple in their kitchen could be a ticking time bomb. The FDA has issued a frantic update after a third-party distributor accidentally shipped thousands of cans of recalled Genova Yellowfin Tuna that…

Budget and the Bees

From analysis to the latest developments in health,
read the most diverse news in one place.

House lawmaker raises new concerns over FDA's ultra-fast drug review program

A Democratic lawmaker is raising new concerns about a Food and Drug Administration program designed to drastically shorten the review of certain drugs

The Independent UK

BioTech Breakout: MoonLake Up 30% On FDA Wins

MoonLake shares are rallying after the FDA granted Fast Track designation for its lead drug and cleared the path for a major filing later this year.

MarketBeat

How To Speed Up the Search for Cures Through a Change in Probability Theory

It seems likely the FDA would do well to accept more Bayesian reasoning in medical research.

Reason

Up 460% in the Past Year, Should You Take a Gamble on This Speculative Stock?

Erasca (ERAS) has surged 460% over the past year, driven by strong technical momentum. ERAS hit a new 3-year high of $10.92 on Monday. Despite bullish technicals, ERAS has no revenue, is burning cash, and its future hinges on FDA drug approvals. Analyst sentiment is highly speculative, with price targets...

Barchart

Read news from The Economist, FT, and more,
with one subscription

FDA Red Alert: Why This Common Blood Pressure Medication Was Just Pulled

You trust that the pill bottle you pick up from the pharmacy is safe. You assume there are rigorous checks and balances before that medication reaches your hands. Unfortunately, the reality of the global pharmaceutical supply chain is far messier. Recently, the FDA issued a recall for the popular blood-pressure…

Budget and the Bees

Why Denmark can't use Ozempic as a trump card with the US in Greenland talks

Novo Nordisk, the Danish manufacturer of weight-loss drugs Ozempic and Wegovy, has a large market share in the US. But it's not enough to put pressure on US President Donald Trump's administration during Greenland talks, experts say.

Euronews

Health Alert: FDA Detects Multiple Pathogens, Dog Food Brand Won’t Recall Products

We treat our pets like family, often buying the most expensive “premium” food to ensure their health. But a disturbing standoff is currently unfolding between federal regulators and a well-known boutique dog food manufacturer.

Budget and the Bees

Major Cheese Recall: FDA Upgrades Risk Level for Boar’s Head and Member’s Mark

Trusting a grocery store is often second nature. Consumers walk in, grab weekly staples, and assume products on the shelf have passed rigorous safety checks. However, that trust was tested this month as the FDA upgraded a nationwide recall for several brands of grated Pecorino Romano cheese to a Class…

Budget and the Bees

Virginia Baby Food Ban: 5 Specific Brands Just Prohibited Under New Safety Laws

Image Source: Shutterstock.com

Kids Ain't Cheap

As billionaires chase immortality, this startup cofounded by a Harvard genetics professor gets FDA approval for the first partial de-aging human trial

Life Biosciences will test its gene therapy designed to partially reset a cell’s age and potentially reverse vision loss in patients with glaucoma and NAION.

Fortune

Cheerios, Pringles and Nutella among thousands of products recalled after exposure to rodent waste

The products were recalled in December due to potential contamination with rodent waste

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

Why drug approval in Canada should not rely on foreign regulators

Without much fanfare, Health Canada announced in the Canada Gazette Part 1 on Dec. 22, 2025 that it was beginning a 70-day consultation period on using the decisions of foreign drug regulators such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to approve new…

The Independent UK

Eye-stroke, vomiting and burst colon: Lawsuits accuse weight-loss drugs of severe side effects

Thousands of patients have filed lawsuits against drug producers claiming side effects - but the companies insist their products are properly tested

The Conversation

Should medical marijuana be less stringently regulated? A drug policy expert explains what’s at stake

Medical marijuana could soon be reclassified into a medical category that includes prescription drugs like Tylenol with codeine, ketamine and anabolic steroids.

International Business Times UK

Kevin O'Leary Reveals How Elites Use a Procedure Not Approved by the FDA for Rapid Cell Regeneration

Shark Tank star Kevin O'Leary recently shared how he undergoes an exotic procedure for rapid cell generation, tissue healing, and a stronger immune system.

Get all your
news in one place.

100's of premium titles.
One news app.

International Business Times

NovaDerm and Solidaris Capital: How Selective Narratives Obscure Regulatory Evasion and Charitable Tax Misuse

Solidaris markets itself as a socially responsible investment platform promising large deductions, but public records and whistleblower reports reveal significant operational discrepancies.

Budget and the Bees

7 New Florida “Nicotine Contraband” Laws: Why Your Local Smoke Shop Might Close This Week

If you walked into your local vape shop this morning and found the shelves looking oddly bare, don’t blame the supply chain. Blame the Florida Attorney General’s “Nicotine Dispensing Device Directory.” While enforcement has been ramping up for a year, the state continues to aggressively target “contraband” nicotine products. However,…

The Independent UK

Stocking up on Keurig pods? You might want to check them as more than 80,000 have been recalled

The affected coffee pods were distributed in three U.S. states

The Guardian - US

Antibiotic use in US meat production jumped 16% in 2024, report shows

Shift raises concerns of increase in antibiotic-resistant ‘superbugs’, which sicken millions of people annually

The Mary Sue

‘This would kill someone’: Kentucky woman opens Ritz. Then she sees something that could pose a serious allergy risk—and it’s not disclosed anywhere

One Kentucky woman thought she was getting regular, buttery Ritz Crackers. Then, she opened the package and smelled something suspicious.

The Independent UK

Chia seeds sold across US recalled over contamination fears

Affected product was sold at Whole Foods and Amazon

The Guardian - UK

Fake weight-loss medication in tablet form could flood Britain, experts warn

Better regulation and enforcement urged before launch of oral treatments, which criminals are likely to try to exploit

1 … 24 25 26 27

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.